NASDAQ, SRDX - Surmodics Inc

Our surface modification and drug delivery technologies are utilized by our  customers to alter the characteristics of the surfaces of devices and biological  materials (e.g., lubricity or hemocompatibility), create new functions for the  surfaces of the devices (e.g., drug delivery or promotion of healing), or enable  drug delivery through our microparticle, polymer implant or device platforms.  For example, our patented PhotoLink? technology enhances the maneuverability of  dilatation catheters and guidewires within the body by improving the lubricity  of the device surface. Similarly, our patented drug delivery technologies can  create new device capabilities by enabling site specific, controlled release  drug delivery in cases where devices are themselves (e.g., stents) necessary to  treat a medical condition and in cases where devices serve only as a vehicle to  deliver a drug (e.g., ophthalmology implants and drug delivery depots).  ...

Sector:	Consumer Durables
Industry:	Major Pharmaceuticals
P/E Ratio:	108.2143
PEG Ratio:	9.77
EPS:	N/A
DivYield:	N/A
PtB:	3.93
PtS:	5.58
EBITDA:	15.57M
Shares:	14.3M
Market Cap:	506.48M
52wk range:	26.00 - 41.32

216.73.216.229
United States